Progressive microglial accumulation at amyloid-b (Ab) plaques is a well-established signature of the pathology of Alzheimer's disease, but how and why microglia accumulate in the vicinity of Ab plaques is unknown. To understand the distinct roles of Ab on microglial accumulation, we quantified microglial responses to week-long lasting gradients of soluble Ab and patterns of surface-bound Ab in microfluidic chemotaxis platforms. We found that human microglia chemotaxis in gradients of soluble Ab 42 was most effective at two distinct concentrations of 23 pg.mL 21 and 23 ng.mL 21 Ab 42 in monomers and oligomers. We uncovered that while the chemotaxis at higher Ab concentrations was exclusively due to Ab gradients, chemotaxis at lower concentrations was enhanced by Ab-induced microglial production of MCP-1. Microglial migration was inhibited by surface-bound Ab 42 in oligomers and fibrils above 45 pg.mm 22 . Better understanding of microglial migration can provide insights into the pathophysiology of senile plaques in AD. M icroglial cells are resident macrophages in the central neural system (CNS) and have multiple functions in normal and pathological brains 1-6 . Ramified microglia are believed to constantly scan the brain and clear the CNS of toxic agents and debris 7,8 . In the context of Alzheimer's disease (AD), diminished clearance of Ab due to impaired microglia is postulated to be one of the mechanisms of Ab plaque formation 9 . Once Ab forms plaques, microglia become hyper-activated 10 , accumulate around the plaques, and consequently secrete neurotoxic agents including neuroinflammatory mediators, reactive oxygen species, and free radicals [11] [12] [13] [14] . Understanding the mechanisms that lead to microglial accumulation and inflammatory responses may provide useful insights into developing strategies for AD treatment. However, several studies report different interactions between microglia and other factors [15] [16] [17] . Previous in vivo studies of microglia migration were hampered by both the inability to observe long-term effects of Ab on microglia 18 and the complexity of senile plaques, which are deposits of oligomeric and fibrillar Ab, surrounded by a ''halo'' of soluble oligomeric Ab 19 , activated glia, and dystrophic neurites 12 . Activated microglial cells take on various morphologies: rounded, ramified shapes, rods to amoeboids, which complicate the visual tracking of these cells individually. Furthermore, previous in vitro attempts to study rat microglia migration in the presence of short lived, damaged axons 20 , could not establish long-lasting gradients and were not conclusive for differentiating slow accumulation of microglia from random navigation 21, 22 .
effective stimulus in recruiting microglia, while insoluble, surfacebound Ab can capture the attracted microglia at the sites of surfacebound Ab (Fig. 1a) . To understand how microglial migration is regulated by Ab in AD, we designed a unique microfluidic chemotactic platform composed of a large central reservoir (100 mL) supplying various types of soluble factors and two side reservoirs (100 mL each) containing medium. Human microglia were loaded in the annular (4 mL) compartment and their migration was observed towards the central (1 mL) compartment ( Fig. 1b-c) . The central and annular compartments were linked by migration channels (10 3 50 3 500 mm 3 in height, width, and length) forming gradients of soluble factors. Compared to a parallel configuration having equal surface areas for cell loading and cell collection, our axisymmetric configuration has a small central cell collecting compartment, which is smaller than a large annular cell loading compartment by a factor of 6. This enhances detection of recruitment. The long and thin migration channels can screen out unwanted entrance of inactivated microglia through mechanical constraints. Using this platform, we observed the migration of microglial cells, at single cell resolution, in real-time, for extended periods (Fig. 1d ). We verified that refreshing media every two days allowed our experimental conditions to have a reasonable degree of physical and chemical stability of soluble Ab forms: 90 and 95% of original Ab gradients of monomeric and oligomeric soluble Ab for up to nine days ( Supplementary Fig. S1 ), 74 and 84% of the total amounts of monomeric and oligomeric Ab solutions for two days ( Supplementary   Fig. S2 ). Thus, for most experiments, we refreshed media including soluble factors every two days. To evaluate the response of microglia to various types of Ab, we tested 200 independent conditions at the same time, by imaging microglia in 8 plates, each with twenty-five platforms in an array format ( Supplementary Fig. S3 ).
Directional migration of microglia towards soluble Ab. To characterize the kinetics of microglial migration driven by soluble Ab, we monitored individual microglial cells exposed to stable gradients of soluble Ab for four days using time-lapse microscopy. We observed that in the first 24 hours after introducing soluble Ab 42 into a reservoir, microglia changed shape, became more elongated, and produced filopodia in random directions ( Fig. 2a , Supplementary Movies S1). However, most of the cells remained stationary for the first 24 hours. Microglia started migrating on the second day of exposure to soluble Ab 42 and migration was directional towards the soluble Ab 42 reservoir (Fig. 2b) . In the absence of soluble Ab 42 , microglia expanded their bodies but did not migrate during fourday experiments (Supplementary Movies S2). We measured comparable effects of monomeric and oligomeric forms, and measured a maximal migration speed of 5.1 6 4.2 mm.hr 21 at 23 ng.mL 21 soluble monomeric Ab 42 ( Fig. 2c ). We observed that microglia also entered the central compartment, the source of 2.3 ng.mL 21 soluble Ab 42 monomers ( Fig. 2d ). Additional quantification of the effect of soluble Ab on cellular distribution was performed by analyzing the changes in cellular density profile over time ( Fig. 2e ). To compare the effect of soluble Ab in various forms and concentrations on microglial recruitment, we defined a recruitment index, R.I. (as defined in Supplementary Methods, Supplementary Fig.  S7 ), representing the fraction of microglia cells recruited to the central compartment after loading soluble Ab in the central compartment. We compared the R.I. values under various types of soluble Ab 42 for eight days ( Fig. 3a, Supplementary Fig. S4 ) and found that the R.I. value reached 5.0 6 0.9 after exposure to monomeric synthetic Ab 42 at 23 ng.mL 21 and 4.0 6 1.0 after exposure to oligomeric forms at 230 ng.mL 21 , on 'day 8' (Fig. 3b ). Measuring the concentration dependence of directional migration speed and R.I. revealed two peaks of activity at two concentrations of soluble Ab 42 that were three orders of magnitude apart (23 pg.mL 21 and 23 ng.mL 21 ) ( Fig. 2c and Fig. 3c ). Interestingly, the low peak concentrations corresponds to the levels in normal and early AD brains, while the high peak to late AD brains 23 .
Microglial recruitment by human-derived soluble Ab. To validate the biological relevance of our platform, we measured the microglial response to gradients of soluble Ab enriched or depleted samples derived from tris-buffered saline (TBS) extracts of human AD brains as previously described 24 . For this purpose, low (8 to 20 kDa) and high molecular weight fractions (more than 100 kDa) were separated by size exclusion chromatography ( Fig. 3d) . Both low-molecular-weight soluble Ab (LMW) and high-molecularweight soluble Ab (HMW) fractions were similar in recruiting microglia towards the central compartment on the eighth day (R.I. 5 3.7 6 0.5 for LMW and R.I. 5 3.9 6 0.6 for HMW) ( Fig. 3e-f ). Removing the soluble Ab by immune-precipitation considerably reduced the microglial accumulation (R.I 5 2.7 6 0.1 for LMW and 2.7 6 0.7 for HMW), suggesting that a major factor of the TBS extract inducing microglial migration was Ab.
Self-promoting microglial recruitment by Ab-induced MCP-1 secretion. Because typical chemotactic responses of various cells display only one activity peak, we investigated further the mechanisms behind the double peak chemotactic activities of microglia in response to Ab. To probe if a second chemoattractant may explain the unusual double chemotactic peak, we utilized a multiplexed cytokine assay to examine 27 cytokines expressed into the media collected from microglia cultured in the presence of soluble Ab 42 at 2.3 pg.mL 21 for two days. We identified five cytokines at detectable levels: IL-1ra, IL-6, IL-8, MCP-1, and MIP-1b while the remaining cytokines were either below, or just at the threshold of detectability ( Fig. 4a) . Arrows indicate saturated measurement of cytokines relative to the standard curve. Because MCP-1, MIP-1a, and MIP-1b are known chemoattractant molecules for macrophages 3,7,25 , we measured microglial recruitment under gradients of soluble Ab 42 in addition to a mixture of neutralizing antibodies against MCP-1, MIB-1a, and MIB-1b and observed reduced activity at 23 pg.mL 21 but not at 23 ng.mL 21 of soluble Ab 42 (Fig. 4c) . In control experiments, we validated that MCP-1 alone can promote microglial recruitment and verified that neutralizing antibodies can reduce microglial recruitment towards the single cytokine ( Fig. 4d) . We further measured the MCP-1 concentration in media from microglia stimulated with various concentrations of both monomeric and oligomeric soluble Ab 42 . We estimated the maximum secretion of MCP-1 at 1,433.9 6 816.0 and 1,457.3 6 109.4 fg.cell 21 in the presence of 2.3 pg.mL 21 of soluble monomeric and oligomeric Ab 42 , respectively and 554.4 6 224.3 fg.cell 21 in the absence of soluble Ab 42 (Fig. 4b) . Interestingly, the MCP-1 secretion in the presence of 2.3 pg.mL 21 Ab 42 was significantly higher than at other concentrations of Ab 42 oligomers. While the migration of microglia occurs at higher levels of the gradient (23 pg.mL 21 ) than uniform Ab 42 (2.3 pg.mL 21 ), the difference could be explained by the lower effective concentration at the initial region of a gradient. It is possible that MCP-1 plays a role in the peak microglia recruitment activity at a gradient of 23 pg.mL 21 soluble Ab 42 , in addition to other reported roles in microgliamediated neurodegeneration 26 . 
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Reduced microglial mobility and viability on Ab fibril-coated surface. In AD brains, microglia presumably migrate towards plaques, and then remain stably associated with the plaques. To examine the mobility of microglia on surface-bound Ab, we prepared wells uniformly coated with surface-bound Ab 42 fibrils and tracked individual microglia cells moving on these surfaces ( Fig. 5a ). We observed that the migration speed of microglia decreased substantially from 26 to 2 mm.hr 21 with an increase of surface-bound Ab 42 concentration from 9 to 1,125 pg.mm 22 , consistent with the possibility that surface-bound Ab 42 inhibited microglial migration (Fig. 5b) . We also observed some of the microglia internalizing particles formed on Ab 42 fibril-coated surfaces, as well as dead cells (Supplementary Movies S3, S4) . At the same time, the viability of microglia decreased substantially on highly concentrated surface-bound Ab 42 . Only 50% of microglia remained viable at 1,125 pg.mm 22 after four days, suggesting acute toxicity of surface-bound Ab fibrils to microglia.
MCP-1 secretion stimulated by surface-bound Ab. The level of secreted MCP-1 was elevated also by bAb about two-fold (1,128.0 6 149.8 and 1,088.7 6 378.2 fg.cell 21 under Ab oligomers and Ab fibrils at 9 ng.mm 22 , respectively) compared to without Ab (554.4 6 96.0 fg.cell 21 ) (Fig. 5c) .
Microglial co-localization with patterned Ab. To further understand how microglia target surface-bound Ab-rich plaques, we patterned surface-bound Ab 42 in both oligomeric and fibril forms on wells at various concentrations by using PDMS stencils of 2 mm holes ( Fig. 5d, Supplementary Fig. S5 ). We quantified the colocalization of microglia on the surface-bound Ab 42 patterns by calculating a localization index (L.I., defined in Supplementary Methods, Supplementary Fig. S8 ), representing the amount of localized cells on the patterned surface-bound Ab relative to the day of microglia plating. We found that microglia co-localized with surface bound Ab 42 patterns at concentrations higher than 45 pg.mm 22 . We measured a L.I. 5 1.4 6 0.1 with oligomers and L.I. 5 1.9 6 0.5 with fibrils at 90 pg.mm 22 on the eighth day ( Fig. 5e-f) .
Microglial recruitment and accumulation in the presence of soluble and patterned Ab. To reconstruct the Ab microenvironment analogous to that encountered by microglia near plaques, a core of fibrillar Ab surrounded by a halo of soluble Ab likely oligomers in the AD brains, we combined patterned surface-bound Ab 42 by using PDMS stencils of 1 mm holes and the gradient of soluble Ab 42 in the microfluidic platform ( Fig. 5g, Supplementary  Fig. S6) . The combination of a gradient of soluble Ab 42 oligomers at (Fig. 5h-i) .
Discussion
Our study demonstrates that soluble monomeric and oligomeric Ab serve as a ''recruiting signal'' and bound fibrillar and oligomeric surface-bound Ab acts as a ''targeting signal'' during microglia recruitment and localization. Together, soluble and insoluble Ab have synergistic effects on microglial accumulation to sites of Ab deposits, and could explain microglial accumulation in the vicinity of Ab plaques in the AD cortex.
Moreover, the MCP-1 dependent mechanism of microglia recruitment in response to lower doses of Ab may be important during physiological neuroinflammation and could be relevant to the early stages of microglial activation in AD. The microfluidic platform can be extended to the study of migration of other cells relevant to the progression of neurodegenerative diseases 27, 28 , and could help quantify the potency of various cytokines and chemokines, which have been detected in the brain alone and in combinations 11 , in modulating microglia recruitment and accumulation. With high-throughput capabilities and regulated microenvironments, our platforms can facilitate systematic monitoring of microglial migration and its modulation by compounds for the treatment of neuroinflammation in various disease conditions, including Alzheimer's disease.
Methods
Microfluidic platform fabrication. Negative photoresists, SU-8 50 and SU-8 100 (MicroChem, Newton, MA, USA), were sequentially patterned using standard lithography on a 4'' silicon wafer to create a mold for cell migration channels of 50 mm in height and chemokine compartments of 100 mm in height. A mixture of a base and a curing agent with a 1051 weight ratio (SYLGARD 184 A/B, Dowcorning, Midland, MI, USA) was poured onto the SU-8 mold and cured for one hour at room temperature under vacuum and, subsequently, cured for more than 3 hours in an oven at 80uC. The cured polydimethyl-siloxane (PDMS) replica was peeled off from the mold and holes were punched for fluid reservoirs. Arrayed holes were also laser-cut (Zing 24, Epilog Laser, Golden, CO, USA) into a thin PDMS membrane of 250 mm in thickness (HT 6240, Bisco Silicones, Elk Grove, IL, USA) and an acrylic plate of 6 mm in thickness. The machined membrane and the plate were glued together using uncured PDMS and incubated at 80uC overnight. This assembly was irreversibly bonded first to the PDMS replica using oxygen plasma at 50 mW, 5 ccm, for 30 seconds (PX-250, March Plasma Systems, Petersburg, FL, USA), and later to a glass-bottomed UniWell plate (MGB001-1-2-LG, Matrical Bioscience, Spokane, WA, USA). Immediately after the bonding, 10 mL of poly (l-lysine) solution (PLL, M.W. 70,000-150,000, 1.0 mg.mL 21 , Sigma-Aldrich Co. LLC, St. Louis, MO, USA) was injected into the each platform and incubated for 2 hours at a room temperature to promote cellular adhesion. PLL-treated surface was rinsed with autoclaved and 0.2 mm filtered water (AM9920, Life Technologies, Grand Island, NY, USA) and then the devices were filled with cell culture medium containing 50550 of DMEM: F-12 supplemented with 5% FBS (Invitrogen, Grand Island, NY, USA), 10 ng.mL 21 of M-CSF (AF-300-25, PeproTech Inc., Rocky Hill, NJ, USA), 25 mg.mL 21 of gentamicin (G1397, Sigma-Aldrich), and 2.5 mg.mL 21 of amphotericin (A2411, Sigma-Aldrich).
Cell preparation. Human microglial cells (HMG 030, Clonexpress, Inc., Gaithersburg, MD, USA) were isolated initially as a free-floating population of cells from fetal brain tissue samples digested with collagenase and grown in a proprietary medium for 1-2 weeks. Before the experiment, cells were washed using medium without serum and the cell membrane was labeled with red fluorescent dye (PKH26PCL, Sigma-Aldrich). After centrifugation (400 g for 5 minutes), the cell pellet was re-suspended in 1 mL of Diluent C (G8278, Sigma-Aldrich) and immediately mixed with 4 mL of dye solution (P9691, Sigma-Aldrich) in 1 mL of Diluent C. The cell/dye mixture was incubated at room temperature for 4 minutes and periodically mixed by pipetting in order to achieve a bright, uniform, and reproducible labeling. After the incubation, the staining was stopped by adding an equal volume (2 mL) of 1% BSA in PBS and incubating for 1 minute to remove excess dye. Unbound dye was washed by centrifuging and re-suspending the cells in the culture medium. Finally, the stained microglia cells were suspended in the culturing medium at the concentration of 1 M cells.mL 21 . Ten mL of cell solution was injected into each platform and 100 mL of a culturing medium was added into side and central extra wells. The loaded cells were incubated at 37uC supplied with 5% CO 2 for at least Co-localization of microglia on the patterned bAb 42 , becomes more effective as the concentration increases with 1.5-fold enrichment on bAb 42 oligomers (e) and 2-fold on bAb fibrils (f) at 90 ng.mm 22 on a 'day 6', respectively. (g) Fluorescent image visualized co-localized microglia on bAb 42 fibrils at 90 ng.mm 22 combined with sAb 42 oligomers at 23 ng.mL 21 in a microfluidic platform. Co-localization is 1.6-fold on bAb 42 fibrils alone (h) compared to 2.5-fold on bAb 42 fibrils at 90 ng.mm 22 in combination with a gradient of sAb 42 oligomers at 23 ng.mL 21 (i). Scale bars, 1 mm. (Student's t-test. * P , 0.1, ** P , 0.05 with respect to no bAb 42 ). n well 5 2 in '(a)', '(b)', '(e)', '(f)' and n platform 5 2, n cell < 2,000 in '(h)', '(i)' for each condition. Data represent mean 6 s.e.m.
www.nature.com/scientificreports two days before adding the various Ab solutions. In the experiments, the cell culture media and Ab solutions were replaced every two days while collecting the used solutions for Ab analysis.
Sourcing of human brain tissue. Brains from human subjects with a diagnosis of Alzheimer's disease were obtained through the Massachusetts Alzheimer's Disease Research Center. The Massachusetts Alzheimer's Disease Research Center (ADRC) serves, among other clinical and research activities, as a repository of samples from patients with Alzheimer's disease. ADRC clinical and research activities are reviewed among others by the Institutional Review Board at the Massachusetts General Hospital. In addition, the ADRC has a Certificate of Confidentiality issued by the US Department of Health & Human Services/National Institutes of Health to protect the privacy of individuals who are enrolled in this research against forced disclosure in any civil, criminal, administrative, legislative or other proceeding, either at the federal, state of local level. The human samples used in this study were anonymised. The Institutional Review Board at the Massachusetts General Hospital viewed the use of anonymized autopsy material for biochemistry assays as exempt from review.
Ab extraction from human brain tissues. Cortical gray matter from frontal lobe of AD patient brains was homogenized in 5 volumes of TBSI (Tris-buffered saline with protease inhibitor cocktail (Roche)) with 25 strokes on a mechanical Dounce homogenizer and centrifuged at 260,000 3 g for 30 min at 4uC. The supernatant was used as a TBS-soluble fraction 28, 29 . 750 mL of TBS-soluble fraction of human brains was separated by a size exclusion chromatography on double superdex 75 columns (GE Healthcare Life Sciences, Piscataway, NJ, USA) in 50 mM ammonium acetate pH 8.5 with an AKTA purifier 10 3, 30 . The individual fractions separated by SEC were analyzed by immunoblotting and Ab specific sandwich ELISA and fraction 6 to 9 (.100 kDa) was used as a HMW Ab and fraction 30 to 33 (20 , 8 kDa) was used as a LMW Ab 30 . Immediately after the size-exclusion chromatography, we removed soluble Ab including soluble alpha Ab precursor protein (APP) from the fractions by immune-depleting with 6E10 antibody (Signet, Dedham, MA, USA).
Time-lapse imaging. For continuous time-lapse imaging to track individual cells, we kept the UniWell plate on a fully automated microscope (Eclipse Ti, Nikon Inc., Melville, NY, USA) integrated with a heated incubating stage (LiveCell 05-11-0032 Rev B, Pathology Devices Inc., Westminster, MD, USA), which was set at 37.7uC, 5% CO 2 , and 85% humidity. We imaged cells at every 1-hour (NIS Elements, Nikon Inc.) using a bright field and every 6-hour using a TRITC fluorescence microscope for 4 days with a 103 objective lens and a perfect focusing system in a phase contrast mode. For continual time-lapse imaging to count cells, we kept the plate in an incubation chamber set at 37.7uC and 5% CO 2 and then imaged it using 43 objective lens in a large-area mode of 8 3 8 mm 2 with a 15% stitching, a phase contrast mode, and a TRITC fluorescent microscope every two-three days for seven days. For continual time-lapse imaging to monitor gradient stability, we kept the plate at room temperature in a dark room, and imaged using 43 objective lens in a large-area mode of 12 3 10 mm 2 without stitching, a phase contrast mode, and a TRITC fluorescent microscope every two-three days for nine days.
